
- /
- Supported exchanges
- / US
- / BIO.NYSE
Bio-Rad Laboratories Inc (BIO NYSE) stock market data APIs
Bio-Rad Laboratories Inc Financial Data Overview
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bio-Rad Laboratories Inc data using free add-ons & libraries
Get Bio-Rad Laboratories Inc Fundamental Data
Bio-Rad Laboratories Inc Fundamental data includes:
- Net Revenue: 2 541 M
- EBITDA: 427 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-05
- EPS/Forecast: 1.7824
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bio-Rad Laboratories Inc News

Life sciences tools companies higher as NIH pauses cancellation of research grants
[Wide Angle Shot of a Clean and Organized Modern Laboratory] Tom Werner * Several life sciences tools companies closed noticably higher Wednesday following a report that the NIH has issued a memo n...


Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence?
Hologic HOLX, a women’s health-focused company, delivered a non-GAAP gross margin of 61.1% in the second quarter of fiscal 2025, up 40 basis points (bps) from the year-ago period. This was fueled by...

Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference
HERCULES, Calif., May 29, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the ...

Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends
Have you looked into how Bio-Rad Laboratories (BIO) performed internationally during the quarter ending March 2025? Considering the widespread global presence of this maker of instruments used in biom...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.